NDC 65847-205

NATRECOR

Nesiritide

NATRECOR is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Scios Llc. The primary component is Nesiritide.

• Product ID: 65847-205_12d931dc-a449-4860-ab9f-20211ff766a0
• NDC: 65847-205
• Product Type: Human Prescription Drug
• Proprietary Name: NATRECOR
• Generic Name: Nesiritide
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2001-08-01
• Marketing Category: NDA / NDA
• Application Number: NDA020920
• Labeler Name: Scios LLC
• Substance Name: NESIRITIDE
• Active Ingredient Strength: 2 mg/5mL
• Pharm Classes: Natriuretic Peptide [EPC],Natriuretic Peptides [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 65847-205-25

1 VIAL, SINGLE-USE in 1 CARTON (65847-205-25) > 5 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2001-08-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 65847-205-25 [65847020525]

NATRECOR INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: NDA
• Application Number: NDA020920
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2001-08-01
• Marketing End Date: 2019-05-30

Drug Details

Active Ingredients

Ingredient	Strength
NESIRITIDE	1.5 mg/5mL

OpenFDA Data

• SPL SET ID: 44c45bfe-461f-4398-8f20-ea771b2403ee
• Manufacturer:
  • Scios LLC
• UNII:
  • P7WI8UL647
• RxNorm Concept Unique ID - RxCUI:
  • 883708
  • 883706

Pharmacological Class

• Natriuretic Peptide [EPC]
• Natriuretic Peptides [CS]